SHIRE PLC
Director/PDMR Shareholding
September 30, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
Notification of transactions by persons discharging managerial responsibilities
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Susan Kilsby
2. Reason for the notification
a) Position / status Chairman - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ("ADSs")
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Acquisition of ADSs, being the part of Ms.
transaction Kilsby's total fees that are paid in ADSs for the
period of service from July 1 to September 30,
2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
$194.99 150
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the NASDAQ Global Select Market
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name William Burns
2. Reason for the notification
a) Position / status Senior Independent Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc Ordinary Shares of 5 pence each
the financial ("Ordinary Shares")
instrument, type
of instrument
Identification ISIN: JE00B2QKY057
code
b) Nature of the Acquisition of Ordinary Shares, being the part of
transaction Mr. Burns' total fees that are paid in Ordinary
Shares for the period of service from July 1 to
September 30, 2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
£50.10 139
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the London Stock Exchange (XLON)
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Dominic Blakemore
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc Ordinary Shares of 5 pence each
the financial ("Ordinary Shares")
instrument, type
of instrument
Identification ISIN: JE00B2QKY057
code
b) Nature of the Acquisition of Ordinary Shares, being the part of
transaction Mr. Blakemore's total fees
that are paid in Ordinary Shares for the period of
service from July 1 to September 30, 2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
£50.10 133
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the London Stock Exchange (XLON)
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Olivier Bohuon
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc Ordinary Shares of 5 pence each
the financial ("Ordinary Shares")
instrument, type
of instrument
Identification ISIN: JE00B2QKY057
code
b) Nature of the Acquisition of Ordinary Shares, being the part of
transaction Mr. Bohuon's total fees that are paid in Ordinary
Shares for the period of service from July 1 to
September 30, 2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
£50.10 131
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the London Stock Exchange (XLON)
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Gail Fosler
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ("ADSs")
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Acquisition of ADSs, being the part of Ms.
transaction Fosler's total fees that are paid in ADSs for the
period of service from July 1 to September 30,
2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
$194.99 49
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the NASDAQ Global Select Market
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Steven Gillis
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ("ADSs")
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Acquisition of ADSs, being the part of Dr. Gillis'
transaction total fees that are paid in ADSs for the period of
service from July 1 to September 30, 2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
$194.99 48
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the NASDAQ Global Select Market
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name David Ginsburg
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ("ADSs")
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Acquisition of ADSs, being the part of Dr.
transaction Ginsburg's total fees that are paid in ADSs for
the period of service from July 1 to September 30,
2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
$194.99 47
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the NASDAQ Global Select Market
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Sara Mathew
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ("ADSs")
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Acquisition of ADSs, being the part of Ms.
transaction Mathew's total fees that are paid in ADSs for the
period of service from July 1 to September 30,
2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
$194.99 46
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the NASDAQ Global Select Market
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Anne Minto
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc Ordinary Shares of 5 pence each
the financial ("Ordinary Shares")
instrument, type
of instrument
Identification ISIN: JE00B2QKY057
code
b) Nature of the Acquisition of Ordinary Shares, being the part of
transaction Ms. Minto's total fees that are paid in Ordinary
Shares for the period of service from July 1 to
September 30, 2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
£50.10 138
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the London Stock Exchange (XLON)
transaction
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Albert Stroucken
2. Reason for the notification
a) Position / status Non-Executive Director - PDMR
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ("ADSs")
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Acquisition of ADSs, being the part of Mr.
transaction Stroucken's total fees that are paid in ADSs for
the period of service from July 1 to September 30,
2016.
c) Price(s) and Price(s) Volume(s)
volume(s)
$194.99 53
d) Aggregated N/A (single transaction)
information
e) Date of the September 30, 2016
transaction
f) Place of the NASDAQ Global Select Market
transaction
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people
with rare diseases and other highly specialized conditions. We strive to
develop best-in-class products, many of which are available in more than 100
countries, across core therapeutic areas including Hematology, Immunology,
Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal /
Internal Medicine / Endocrine and Hereditary Angioedema; and a growing
franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and
deliver breakthrough therapies for the hundreds of millions of people in the
world affected by rare diseases and other high-need conditions, and who lack
effective therapies to live their lives to the fullest.
www.shire.com
SHIRE PLC : - Director/PDMR Shareholding
September 30, 2016 at 11:21 am EDT
Share
Share
© PRNewswire - 2016
